This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, Y.
Right arrow Articles by Ohsuye, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, Y.
Right arrow Articles by Ohsuye, K.
Agricola
Right arrow Articles by Suzuki, Y.
Right arrow Articles by Ohsuye, K.

 Previous Article  |  Next Article 

Appl Environ Microbiol, February 1998, p. 526-529, Vol. 64, No. 2
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

High-Level Production of Recombinant Human Parathyroid Hormone 1-34

Yuji Suzuki,* Masayuki Yabuta, and Kazuhiro Ohsuye

Suntory Institute for Medicinal Research and Development, 2716-1 Akaiwa, Chiyoda-machi, Ohra-Gun, Gunma 370-05, Japan

Received 3 September 1997/Accepted 31 October 1997

Expression of the synthetic human parathyroid hormone 1-34 [hPTH(1-34)] gene by a gene fusion strategy was demonstrated. hPTH(1-34) was produced at the C terminus of the partner peptides involving amino acids 1 to 97, 1 to 117, or 1 to 139 of a modified Escherichia coli beta -galactosidase by linker peptides containing oligohistidine of different lengths. The fusion proteins in the inclusion bodies were rendered soluble with urea and subjected to site-specific cleavage with the secretory type yeast Kex2 protease. Optimal expression and enzymatic processing were achieved in the fusion protein beta G-117S4HPT, constructed from amino acids 1 to 117 of beta -galactosidase and the linker of HHHHPGGSVKKR. The fusion protein accumulated more than 20% of the E. coli total protein. The hPTH(1-34) was purified up to 99.5% with a good yield of 0.5 g/liter of culture. The purified product was identified as intact hPTH(1-34) by amino acid analysis and N-terminal sequencing.


* Corresponding author. Mailing address: Suntory Institute for Medicinal Research and Development, 2716-1 Akaiwa, Chiyoda-machi, Ohra-Gun, Gunma 370-05, Japan. Phone: 81(276) 86-5784. Fax: 81(276) 86-5760. E-mail: 100545{at}116.mail.suntory.co.jp.




This article has been cited by other articles:

  • Okuno, K., Yabuta, M., Ooi, T., Kinoshita, S. (2004). Utilization of Escherichia coli Outer-Membrane Endoprotease OmpT Variants as Processing Enzymes for Production of Peptides from Designer Fusion Proteins. Appl. Environ. Microbiol. 70: 76-86 [Abstract] [Full Text]